Literature DB >> 10780274

Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers.

N Jourenkova-Mironova1, H Wikman, C Bouchardy, K Mitrunen, P Dayer, S Benhamou, A Hirvonen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780274

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


× No keyword cloud information.
  6 in total

1.  NAT2 polymorphisms with oral carcinoma susceptibility: a meta-analysis.

Authors:  Xian-Lu Zhuo; Jun-Jun Ling; Yan Zhou; Hou-Yu Zhao; Yu-Feng Song; Ying-Hui Tan
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

2.  N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case-control studies.

Authors:  Liang Zhang; Zhaolan Xiang; Rui Hao; Ru Li; Yi Zhu
Journal:  Tumour Biol       Date:  2013-12-13

3.  Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.

Authors:  Xin-Jiang Ying; Pin Dong; Bin Shen; Jie Wang; Sang Wang; Guo Wang
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-30       Impact factor: 4.553

4.  Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis.

Authors:  Youyang Zheng; Yong Li; Yaoshu Teng; Zhen Zhang; Xiaolin Cao
Journal:  Oncol Lett       Date:  2011-11-24       Impact factor: 2.967

5.  Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes.

Authors:  Shama C Buch; Valle Nazar-Stewart; Joel L Weissfeld; Marjorie Romkes
Journal:  Head Neck       Date:  2008-09       Impact factor: 3.147

6.  Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.

Authors:  Mousumi Majumder; Saurabh Ghosh; Bidyut Roy
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.